Medicare Enrolled

Dr. Mark Kozloff, MD

Hematology & Oncology · Harvey, IL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
71 W 156TH ST, Harvey, IL 60426
7083394800
In practice since 2006 (20 years)
NPI: 1134166879 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kozloff from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kozloff? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kozloff

Dr. Mark Kozloff is a hematology & oncology specialist in Harvey, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kozloff performed 1,346 Medicare services across 530 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kozloff received a total of $405,883 from 63 pharmaceutical and/or device companies across 811 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kozloff is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 44% volume in IL $405,883 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,346
Medicare services
Top 44% in IL for hematology & oncology
530
Unique beneficiaries
$94
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~67 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
837 $97 $239
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
208 $62 $163
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
141 $138 $322
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
101 $66 $162
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
33 $97 $235
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
13 $115 $371
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
13 $109 $424
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$405,883
Total received (2018-2024)
Avg $57,983/year across 7 years
Top 1% in IL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
811
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$306,672 (75.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$89,483 (22.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,727 (2.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,395
2023
$3,018
2022
$11,413
2021
$7,354
2020
$18,988
2019
$156,342
2018
$204,374

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$385
Genentech USA, Inc.
$361
Merck Sharp & Dohme LLC
$350
Novartis Pharmaceuticals Corporation
$343
Incyte Corporation
$282
Takeda Pharmaceuticals U.S.A., Inc.
$266
PFIZER INC.
$243
Janssen Biotech, Inc.
$220
ABBVIE INC.
$209
Daiichi Sankyo Inc.
$183
SOBI, INC
$183
Regeneron Healthcare Solutions, Inc.
$166
E.R. Squibb & Sons, L.L.C.
$158
Gilead Sciences, Inc.
$134
Eisai Inc.
$133
Astellas Pharma US Inc
$103
Ipsen Biopharmaceuticals, Inc
$73
Deciphera Pharmaceuticals Inc.
$61
GENZYME CORPORATION
$56
BeiGene USA, Inc.
$55
EMD Serono, Inc.
$53
Janssen Pharmaceuticals, Inc
$48
Tempus AI, Inc
$48
Pharmacosmos Therapeutics Inc.
$46
Celgene Corporation
$41
Mirati Therapeutics, Inc.
$40
Adaptive Biotechnologies Corporation
$31
JAZZ PHARMACEUTICALS INC.
$28
GlaxoSmithKline, LLC.
$27
Bayer Healthcare Pharmaceuticals Inc.
$26
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
PUMA BIOTECHNOLOGY, INC.
$21
Top 3 companies account for 24.9% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$98,105
Celgene Corporation
$65,968
Merck Sharp & Dohme Corporation
$65,820
Rigel Pharmaceuticals, Inc.
$56,279
AbbVie, Inc.
$35,518
Amgen Inc.
$22,365
Bayer HealthCare Pharmaceuticals Inc.
$9,010
Boehringer Ingelheim Pharmaceuticals, Inc.
$8,694
Merck Sharp & Dohme LLC
$7,366
Novartis Pharmaceuticals Corporation
$6,829
F. Hoffmann-La Roche AG
$5,719
TESARO, Inc.
$4,932
Dova Pharmaceuticals
$3,163
Lilly USA, LLC
$2,993
BeiGene USA, Inc.
$2,175
Seagen Inc.
$1,282
Seattle Genetics, Inc.
$1,155
AstraZeneca Pharmaceuticals LP
$811
Janssen Biotech, Inc.
$738
Incyte Corporation
$733
Epizyme, Inc.,
$548
PFIZER INC.
$542
Takeda Pharmaceuticals U.S.A., Inc.
$492
E.R. Squibb & Sons, L.L.C.
$399
Gilead Sciences, Inc.
$385
SANOFI-AVENTIS U.S. LLC
$344
Daiichi Sankyo Inc.
$327
Regeneron Healthcare Solutions, Inc.
$315
Astellas Pharma US Inc
$263
ABBVIE INC.
$241
Eisai Inc.
$238
SOBI, INC
$183
EMD Serono, Inc.
$176
JAZZ PHARMACEUTICALS INC.
$123
Pharmacyclics LLC, An AbbVie Company
$114
Deciphera Pharmaceuticals Inc.
$111
GENZYME CORPORATION
$102
Kite Pharma, Inc.
$99
SERVIER PHARMACEUTICALS LLC
$99
Cardinal Health 414 LLC
$87
Bayer Healthcare Pharmaceuticals Inc.
$77
Janssen Pharmaceuticals, Inc
$76
Ipsen Biopharmaceuticals, Inc
$73
MorphoSys, US Inc.
$68
CTI BioPharma Corp.
$67
G1 Therapeutics, Inc.
$65
Karyopharm Therapeutics Inc.
$65
Mirati Therapeutics, Inc.
$59
GlaxoSmithKline, LLC.
$51
Tempus AI, Inc
$48
Pharmacosmos Therapeutics Inc.
$46
EISAI INC.
$45
Exelixis Inc.
$42
AbbVie Inc.
$41
Adaptive Biotechnologies Corporation
$31
GE HealthCare
$30
Sumitomo Pharma America, Inc.
$29
Puma Biotechnology, Inc.
$26
Myriad Genetic Laboratories, Inc.
$25
EUSA Pharma (US) LLC
$24
PUMA BIOTECHNOLOGY, INC.
$21
ADC Therapeutics America, Inc.
$19
Global Blood Therapeutics, Inc.
$16
Top 3 companies account for 56.6% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ALUNBRIG · Abraxane · Adcetris · Alecensa · Avastin · BAVENCIO · BOSULIF · BRUKINSA · Bavencio · Blincyto · CABLIVI · CALQUENCE · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ENHERTU · ENJAYMO · ERLEADA · Enhertu · FRUZAQLA · GAZYVA · GILOTRIF · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Itovebi · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · NINLARO · Non-Covered Product · Nplate · Nubeqa · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · PADCEV · PIQRAY · PLUVICTO · Padcev · Perjeta · Polivy · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · Rituxan · SARCLISA · SCEMBLIX · SUTENT · Stivarga · Sylvant · TASIGNA · TAZVERIK · TECENTRIQ · TUKYSA · Tarceva · Tavalisse · Tecentriq · Tibsovo · Trodelvy · VENCLEXTA · VERZENIO · VONJO · Vectibix · Venclexta · Vonjo · XALKORI · XARELTO · XPOVIO · XTANDI · Xospata · Yescarta · ZEJULA · ZEPZELCA · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for hematology & oncology in IL.

Looking for a hematology & oncology specialist in Harvey?
Compare hematology & oncology specialists in the Harvey area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
285
Per 100K population
5.5
County median income
$81,797
Nearest hospital
INGALLS MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kozloff is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of IL peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kozloff experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kozloff performed 837 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kozloff receive payments from pharmaceutical companies?
Yes. Dr. Kozloff received a total of $405,883 from 63 companies across 811 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kozloff's costs compare to other hematology & oncology specialists in Harvey?
Dr. Kozloff's average Medicare payment per service is $94. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kozloff) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →